VARSINAIS-SUOMEN HYVINVOINTIALUE

Their core work

Varsinais-Suomen Hyvinvointialue is the regional wellbeing services authority for Southwest Finland, operating the Turku University Hospital and associated healthcare infrastructure. In H2020 projects, they contribute real-world clinical data, patient cohorts, and hospital-based expertise to European health research consortia. Their participation spans cancer treatment, sleep medicine, infectious disease surveillance, and AI-driven diagnostics — reflecting their role as a large clinical partner capable of validating research in actual care settings.

What they specialise in

How they've shifted over time

Their earliest H2020 involvement (2019) centred on interventional oncology — specifically MR-guided focused ultrasound for palliative cancer care, paired with health economics evaluation. By 2021, their focus shifted decisively toward AI and data-driven medicine: machine learning for sleep diagnostics, artificial intelligence for cancer treatment decisions, and large-scale epidemiological surveillance. This trajectory shows a clinical institution moving from device-based treatment research toward digital health and AI-assisted care.

They are rapidly building capacity in clinical AI applications, making them a strong partner for projects needing hospital-validated machine learning and real-world patient data.

How they like to work

They participate exclusively as a consortium partner, never coordinating — consistent with their role as a clinical data provider and validation site rather than a research initiator. With 81 unique partners across 23 countries from just 4 projects, they join large, pan-European consortia. This makes them an accessible partner: they are experienced in multi-site collaboration and comfortable contributing clinical expertise within big, distributed teams.

Despite only 4 projects, they have collaborated with 81 unique partners across 23 countries, indicating involvement in very large consortia with broad European reach. Their network spans clinical, academic, and technology partners across most EU member states.

What sets them apart

As a Finnish regional health authority operating a university hospital, they offer something rare: direct access to structured Nordic patient data within a healthcare system known for its digital maturity and comprehensive registries. Finland's national health data infrastructure — including integrated electronic health records and population-level registries — makes them an exceptionally valuable clinical validation partner. For consortium builders, they bring the combination of high-quality real-world data, ethical data governance, and the clinical infrastructure to test AI solutions in routine care.

Highlights from their portfolio

• DECIDER
  Largest funding share (EUR 732K) and combines AI, multi-level data integration, and personalised cancer medicine — their flagship H2020 contribution.
• FURTHER
  Unusual combination of MR-guided focused ultrasound with health economics evaluation for palliative bone metastasis treatment.
• SLEEP REVOLUTION
  Applies deep learning and AI to revolutionize sleep diagnostics, representing their push into digital health and personalized care.